Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bronchiolitis Obliterans
Bronchiolitis obliterans can limit survival after lung transplantation
September 9th, 2004
Although bronchiolitis obliterans negatively affects quality of life, some patients may still benefit from lung transplantation.
According to recent research published in the journal Clinical Transplantation, "Bronchiolitis obliterans syndrome (BOS) is the most important factor limiting long-term survival after lung transplantation, and has a substantial impact on patients' daily life in terms of disability and morbidity."
"The aim of our study was to examine the effects of BOS on health related quality of life (HRQL) in lung transplantation patients. Data on HRQL from 29 patients who developed BOS at least 18 months earlier were...
Source: Blood Weekly (2004-09-09)
|
|
|
